About Us

Our Mission

The PCCTC’s distinguished investigators work together on a single mission: to design, implement and complete hypothesis-driven trials in prostate cancer, translating scientific discoveries to improved standards of care. We offer contract research organization (CRO) services to carry out this mission ensuring efficient trial selection, reporting, site management, clinical operations, and data analyses.

Our History

The Prostate Cancer Clinical Trials Consortium (PCCTC) was initiated in 2005 by the Prostate Cancer Foundation (PCF) and the U.S. Department of Defense (DOD) Prostate Cancer Research Program (PCRP) in response to critically unmet needs in prostate cancer clinical research identified by physician investigators and patient advocates. To fulfill our mission, we developed a unique infrastructure which has fostered a culture of transparent project co-development between investigators, research sites and industry partners. Established as an independent CRO in 2014, the PCCTC, LLC is now the nation’s premier multicenter clinical research organization specializing in cutting-edge prostate cancer research. Through the collaborative nature and intellectual synergy of our leadership, the PCCTC remains poised to make a significant impact on the lives of patients by keeping the pipeline primed with the most promising novel agents and validated biomarkers.

Our Leadership

Management Team

Jake Vinson


Howard I. Scher, MD

Chairman, Scientific
Oversight Committee

Michael J. Morris, MD

Medical Director

Sarah Wise

Director, Research Operations

Rebecca Green

Director, Clinical Operations

Michelle Karlin

Director, Business Development
and Operations

Travis Gerke

Director, Data Science

Joy Allen

Director, Data Management and Informatics

Board of Managers

Peter T. Scardino, MD, Chairman

Paul Sabbatini, MD, MSKCC Designated Officer

Mark Svenningson, Treasurer

Howard I. Scher, MD, Scientific Oversight Committee Chairman

Charles L. Sawyers, MD, Member

Leo F. Mullin, Member

Scientific Oversight Committee

Howard I. Scher, MD (Chairman), Memorial Sloan Kettering Cancer Center

Mary-Ellen Taplin, MD, Dana-Farber / Harvard Cancer Center

Andrew Armstrong, MD, MSc, Duke Comprehensive Cancer Center

Channing Paller, MD, Johns Hopkins Sidney Kimmel
Comprehensive Cancer Center

Tomasz M. Beer, MD, Oregon Health and Science University
Knight Cancer Institute

Rahul Aggarwal, MD, University of California, San Francisco

Russell Szmulewitz, MD, University of Chicago

Emmanuel Antonarakis, MD, University of Minnesota Twin Cities

Heather Cheng, MD, PhD, University of Washington Fred Hutchinson
Cancer Research Center

Glenn Liu, MD, University of Wisconsin Carbone Cancer Center

Elisabeth Heath, MD, Barbara Ann Karmanos Cancer Institute

Scott Tagawa, MD, MS, Weill Cornell Medical College & Columbia University

Our Participants

Participating Clinical Research Sites

The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Beth Israel Deaconess Medical Center

Carolina Urologic Research Center

Charlotte-Mecklenburg Hospital Authority - Atrium Health

Chesapeake Urology Research Associates

Christiana Care Health Services

City of Hope National Medical Center

Cleveland Clinic Foundation

Comprehensive Cancer Center at Rhode Island Hospital

Comprehensive Cancer Center Nevada - US Oncology

Dana-Farber Cancer Institute

The DMH Cancer Care Institute

Duke Cancer Institute

GU Research Network

H. Lee Moffitt Cancer Center

Herbert Irving Comprehensive Cancer Center (at Columbia University)

Houston Methodist Cancer Center

Huntsman Cancer Institute at the University of Utah

Indiana University Melvin and Bren Simon Cancer Center

Karmanos Cancer Center

The Masonic Cancer Center, University of Minnesota

Mass General Cancer Center

Mayo Clinic - Arizona

Mayo Clinic - Jacksonville

Mayo Clinic - Rochester

MD Anderson Cancer Center at Cooper

Memorial Sloan Kettering Cancer Center

Midlantic Urology

Moores Cancer Center at UC San Diego Health

MUSC Hollings Cancer Center

Nevada Cancer Research Foundation

New Mexico Cancer Care Alliance

NorthShore University Health System

NorthShore Kellogg Cancer Center

Northwestern Medicine, Warrenville and Delnor

Ochsner Medical Center

OHSU Knight Cancer Institute

O'Neal Comprehensive Cancer Center at UAB

OU Health Stephenson Cancer Center

Precision Cancer Research - Dayton

Precision Cancer Research - New Mexico

Robert H. Lurie Comprehensive Cancer Center of the Northwestern University Feinberg School of Medicine

Roswell Park Comprehensive Cancer Center

Rush University Cancer Center

Rutgers Cancer Institute of New Jersey

Sidney Kimmel Cancer Center at Jefferson

Tulane Cancer Center

UCLA Jonsson Comprehensive Cancer Center

UCSF Helen Diller Family Comprehensive Cancer Center

UF Health Cancer Center

UMass Memorial Health Care Cancer Center

UNC Lineberger Comprehensive Cancer Center

University of Chicago Comprehensive Cancer Center

University of Illinois Cancer Center

University of Maryland Marlene and Stewart Greenebaum Cancer Center

University of Michigan Rogel Cancer Center

University of Virginia Cancer Center

University of Washington Medical Center & Seattle Cancer Care Alliance

University Wisconsin Carbone Cancer Center

UNM Comprehensive Cancer Center

Virginia Oncology Associates

Weill Cornell Medicine Sandra and Edward Meyer Cancer Center

Wilmot Cancer Institute - University of Rochester Medical Center

Winship Cancer Institute of Emory University

University of Minnesota

University of New Mexico

Yale Cancer Center

Committed to world-class science!

Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.